{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:08Z","timestamp":1786988048394,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejim.2018.11.011","type":"journal-article","created":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T08:20:27Z","timestamp":1543652427000},"page":"71-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Antipsychotics and severe hyponatremia: A Swedish population\u2013based case\u2013control study"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-6987","authenticated-orcid":false,"given":"Henrik","family":"Falhammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatan D.","family":"Lindh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Calissendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buster","family":"Mannheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2018.11.011_bb0005","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.amjmed.2006.05.005","article-title":"Incidence and prevalence of hyponatremia","volume":"119","author":"Upadhyay","year":"2006","journal-title":"Am J Med"},{"issue":"71","key":"10.1016\/j.ejim.2018.11.011_bb0010","first-page":"e1","article-title":"Mild chronic hyponatremia is associated with falls, unsteadiness and attention deficits","volume":"119","author":"Renneboog","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2018.11.011_bb0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/jgs.13325","article-title":"Symptoms and characteristics of individuals with profound hyponatremia: a prospective multicenter observational study","volume":"63","author":"Nigro","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2018.11.011_bb0020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2018.11.011_bb0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.ajkd.2008.03.004","article-title":"A review of drug-induced hyponatremia","volume":"52","author":"Liamis","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.ejim.2018.11.011_bb0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjmed.2017.07.025","article-title":"Differences in associations of antidepressants and hospitalization due to hyponatremia","volume":"131","author":"Farmand","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2018.11.011_bb0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.seizure.2018.04.025","article-title":"Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: a population-based case-control study","volume":"59","author":"Falhammar","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.ejim.2018.11.011_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/11319070-000000000-00000","article-title":"Antipsychotic-induced hyponatraemia: a systematic review of the published evidence","volume":"33","author":"Meulendijks","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.ejim.2018.11.011_bb0045","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2165\/11532560-000000000-00000","article-title":"Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase","volume":"33","author":"Mannesse","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.ejim.2018.11.011_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40697-016-0111-z","article-title":"Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study","volume":"3","author":"Gandhi","year":"2016","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.ejim.2018.11.011_bb0055","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/TCRM.S117321","article-title":"Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review","volume":"13","author":"Solmi","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ejim.2018.11.011_bb0060","article-title":"Quetiapine-Induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone","volume":"2016","author":"Koufakis","year":"2016","journal-title":"Case Rep Psychiatry"},{"key":"10.1016\/j.ejim.2018.11.011_bb0065","doi-asserted-by":"crossref","first-page":"878","DOI":"10.4103\/jfmpc.jfmpc_205_17","article-title":"A case report of rapid-onset hyponatremia induced by low-dose olanzapine","volume":"6","author":"Anil","year":"2017","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.ejim.2018.11.011_bb0070","article-title":"Management of Persistent Hyponatremia Induced by Long-acting Injectable Risperidone Therapy","volume":"10","author":"Chowdhury","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.ejim.2018.11.011_bb0075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00213-017-4525-9","article-title":"Antipsychotic use is a risk factor for hyponatremia in patients with schizophrenia: a 15-year follow-up study","volume":"234","author":"Yang","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejim.2018.11.011_bb0080","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1210\/JC.2015-2093","article-title":"Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a swedish population-based national cohort study","volume":"100","author":"Falhammar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2018.11.011_bb0085","article-title":"Associations of proton pump inhibitors and hospitalization due to hyponatremia: a population-based case-control study","author":"Falhammar","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2018.11.011_bb0090","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"10.1016\/j.ejim.2018.11.011_bb0095","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1210\/jc.2017-01139","article-title":"Reduced frequency of biological and increased frequency of adopted children in males with 21-hydroxylase deficiency: a swedish population-based national cohort study","volume":"102","author":"Falhammar","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2018.11.011_bb0100","author":"R: A language and environment for statistical computing"},{"key":"10.1016\/j.ejim.2018.11.011_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF03256181","article-title":"Hyponatraemia associated with psychotropic medications. A review of the literature and spontaneous reports","volume":"21","author":"Madhusoodanan","year":"2002","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"10.1016\/j.ejim.2018.11.011_bb0110","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/106002809502907-801","article-title":"Water handling in patients receiving haloperidol decanoate","volume":"29","author":"Rider","year":"1995","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejim.2018.11.011_bb0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hup.825","article-title":"Atypical antipsychotics and polydipsia: a cause or a treatment?","volume":"22","author":"Bersani","year":"2007","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.ejim.2018.11.011_bb0120","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1368-5031.2005.00532.x","article-title":"PIP syndrome: a potentially threatening manifestation of a psychiatric disorder","volume":"59","author":"Lydakis","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ejim.2018.11.011_bb0125","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archinte.1980.00330230085018","article-title":"Hyponatremia in psychogenic polydipsia","volume":"140","author":"Hariprasad","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2018.11.011_bb0130","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.4103\/0976-500X.120942","article-title":"Pharmacovigilance in Italy: an overview","volume":"4","author":"Mazzitello","year":"2013","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.ejim.2018.11.011_bb0135","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ijcard.2015.10.002","article-title":"The importance of pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy","volume":"202","author":"Sportiello","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2018.11.011_bb0140","doi-asserted-by":"crossref","first-page":"d4551","DOI":"10.1136\/bmj.d4551","article-title":"Antidepressant use and risk of adverse outcomes in older people: population based cohort study","volume":"343","author":"Coupland","year":"2011","journal-title":"BMJ (Clinical Research ed)"},{"key":"10.1016\/j.ejim.2018.11.011_bb0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011200","article-title":"Antidepressants and the risk of hyponatremia: a Danish register-based population study","volume":"6","author":"Leth-Moller","year":"2016","journal-title":"BMJ Open"}],"updated-by":[{"DOI":"10.1016\/j.ejim.2021.05.042","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000}}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518304631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518304631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T20:03:57Z","timestamp":1549051437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620518304631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":29,"alternative-id":["S0953620518304631"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2018.11.011","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotics and severe hyponatremia: A Swedish population\u2013based case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2018.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}